Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 520

1.

Native myocardial T1 time can predict development of subsequent anthracycline-induced cardiomyopathy.

Muehlberg F, Funk S, Zange L, von Knobelsdorff-Brenkenhoff F, Blaszczyk E, Schulz A, Ghani S, Reichardt A, Reichardt P, Schulz-Menger J.

ESC Heart Fail. 2018 Apr 19. doi: 10.1002/ehf2.12277. [Epub ahead of print]

PMID:
29673122
2.

Chemotherapeutic Drug Based Metal-Organic Particles for Microvesicle-Mediated Deep Penetration and Programmable pH/NIR/Hypoxia Activated Cancer Photochemotherapy.

Zhang D, Wu M, Cai Z, Liao N, Ke K, Liu H, Li M, Liu G, Yang H, Liu X, Liu J.

Adv Sci (Weinh). 2018 Jan 3;5(2):1700648. doi: 10.1002/advs.201700648. eCollection 2018 Feb.

4.

Distribution of Glutathione-Stabilized Gold Nanoparticles in Feline Fibrosarcomas and Their Role as a Drug Delivery System for Doxorubicin-Preclinical Studies in a Murine Model.

Zabielska-Koczywąs K, Wojtalewicz A, Użarowska E, Klejman A, Wojtkowska A, Dolka I, Wojnicki M, Sobczak K, Wójcik M, Shen H, Ferrari M, Lechowski R.

Int J Mol Sci. 2018 Mar 29;19(4). pii: E1021. doi: 10.3390/ijms19041021.

5.

Multifunctional fluorescent titania nanoparticles: green preparation and applications as antibacterial and cancer theranostic agents.

Masoudi M, Mashreghi M, Goharshadi E, Meshkini A.

Artif Cells Nanomed Biotechnol. 2018 Mar 29:1-12. doi: 10.1080/21691401.2018.1454932. [Epub ahead of print]

PMID:
29595338
6.

<i>E. coli</i> Nissle 1917-Derived Minicells for Targeted Delivery of Chemotherapeutic Drug to Hypoxic Regions for Cancer Therapy.

Zhang Y, Ji W, He L, Chen Y, Ding X, Sun Y, Hu S, Yang H, Huang W, Zhang Y, Liu F, Xia L.

Theranostics. 2018 Feb 12;8(6):1690-1705. doi: 10.7150/thno.21575. eCollection 2018.

7.

Cooperative Assembly of Magneto-Nanovesicles with Tunable Wall Thickness and Permeability for MRI-Guided Drug Delivery.

Yang K, Liu Y, Liu Y, Zhang Q, Kong C, Yi C, Zhou Z, Wang Z, Zhang G, Zhang Y, Khashab NM, Chen X, Nie Z.

J Am Chem Soc. 2018 Apr 4;140(13):4666-4677. doi: 10.1021/jacs.8b00884. Epub 2018 Mar 21.

PMID:
29543442
8.

Y<sub>1</sub> receptor ligand-based nanomicelle as a novel nanoprobe for glioma-targeted imaging and therapy.

Li J, Du Y, Jiang Z, Tian Y, Qiu N, Wang Y, Lqbal MZ, Hu M, Zou R, Luo L, Du S, Tian J, Wu A.

Nanoscale. 2018 Mar 29;10(13):5845-5851. doi: 10.1039/c8nr00148k.

PMID:
29542782
9.

Biomimetic Persistent Luminescent Nanoplatform for Autofluorescence-Free Metastasis Tracking and Chemophotodynamic Therapy.

Li YJ, Yang CX, Yan XP.

Anal Chem. 2018 Mar 20;90(6):4188-4195. doi: 10.1021/acs.analchem.8b00311. Epub 2018 Mar 9.

PMID:
29504391
10.

Fabrication of BSA@AuNC-Based Nanostructures for Cell Fluoresce Imaging and Target Drug Delivery.

Ding C, Xu Y, Zhao Y, Zhong H, Luo X.

ACS Appl Mater Interfaces. 2018 Mar 14;10(10):8947-8954. doi: 10.1021/acsami.7b18493. Epub 2018 Mar 5.

PMID:
29457719
11.

Novel Core-Interlayer-Shell DOX/ZnPc Co-loaded MSNs@ pH-Sensitive CaP@PEGylated Liposome for Enhanced Synergetic Chemo-Photodynamic Therapy.

Ma J, Wu H, Li Y, Liu Z, Liu G, Guo Y, Hou Z, Zhao Q, Chen D, Zhu X.

Pharm Res. 2018 Feb 8;35(3):57. doi: 10.1007/s11095-017-2295-z.

PMID:
29423532
12.

Enhanced Synergism of Thermo-chemotherapy For Liver Cancer with Magnetothermally Responsive Nanocarriers.

Li M, Bu W, Ren J, Li J, Deng L, Gao M, Gao X, Wang P.

Theranostics. 2018 Jan 1;8(3):693-709. doi: 10.7150/thno.21297. eCollection 2018.

13.

In Situ shRNA Synthesis on DNA-Polylactide Nanoparticles to Treat Multidrug Resistant Breast Cancer.

Ni Q, Zhang F, Zhang Y, Zhu G, Wang Z, Teng Z, Wang C, Yung BC, Niu G, Lu G, Zhang L, Chen X.

Adv Mater. 2018 Mar;30(10). doi: 10.1002/adma.201705737. Epub 2018 Jan 15.

PMID:
29333658
14.

Toxic Reactive Oxygen Species Enhanced Synergistic Combination Therapy by Self-Assembled Metal-Phenolic Network Nanoparticles.

Dai Y, Yang Z, Cheng S, Wang Z, Zhang R, Zhu G, Wang Z, Yung BC, Tian R, Jacobson O, Xu C, Ni Q, Song J, Sun X, Niu G, Chen X.

Adv Mater. 2018 Feb;30(8). doi: 10.1002/adma.201704877. Epub 2018 Jan 8.

PMID:
29315862
15.

Assessment of doxorubicin-induced mouse testicular damage by the novel second-harmonic generation microscopy.

Yang CC, Chen YT, Chen CH, Chiang JY, Zhen YY, Yip HK.

Am J Transl Res. 2017 Dec 15;9(12):5275-5288. eCollection 2017.

16.

Self-Assembled Coumarin Nanoparticle in Aqueous Solution as Selective Mitochondrial-Targeting Drug Delivery System.

Lee JH, Kim KY, Jin H, Baek YE, Choi Y, Jung SH, Lee SS, Bae J, Jung JH.

ACS Appl Mater Interfaces. 2018 Jan 31;10(4):3380-3391. doi: 10.1021/acsami.7b17711. Epub 2018 Jan 16.

PMID:
29302967
17.

Tumor-penetrating Peptide Conjugated and Doxorubicin Loaded T<sub>1</sub>-T<sub>2</sub> Dual Mode MRI Contrast Agents Nanoparticles for Tumor Theranostics.

Gao L, Yu J, Liu Y, Zhou J, Sun L, Wang J, Zhu J, Peng H, Lu W, Yu L, Yan Z, Wang Y.

Theranostics. 2018 Jan 1;8(1):92-108. doi: 10.7150/thno.21074. eCollection 2018.

18.

Deformable Hollow Periodic Mesoporous Organosilica Nanocapsules for Significantly Improved Cellular Uptake.

Teng Z, Wang C, Tang Y, Li W, Bao L, Zhang X, Su X, Zhang F, Zhang J, Wang S, Zhao D, Lu G.

J Am Chem Soc. 2018 Jan 31;140(4):1385-1393. doi: 10.1021/jacs.7b10694. Epub 2018 Jan 3.

PMID:
29281272
19.

Modularized peptides modified HBc virus-like particles for encapsulation and tumor-targeted delivery of doxorubicin.

Shan W, Zhang D, Wu Y, Lv X, Hu B, Zhou X, Ye S, Bi S, Ren L, Zhang X.

Nanomedicine. 2018 Apr;14(3):725-734. doi: 10.1016/j.nano.2017.12.002. Epub 2017 Dec 21.

PMID:
29275067
20.

Metal ion assisted interface re-engineering of a ferritin nanocage for enhanced biofunctions and cancer therapy.

Wang Z, Dai Y, Wang Z, Jacobson O, Zhang F, Yung BC, Zhang P, Gao H, Niu G, Liu G, Chen X.

Nanoscale. 2018 Jan 18;10(3):1135-1144. doi: 10.1039/c7nr08188j.

PMID:
29271453

Supplemental Content

Loading ...
Support Center